Secondary Breast Cancer Barts Health

Listing Websites about Secondary Breast Cancer Barts Health

Filter Type:

Breast cancer at Barts Health NHS Trust

(4 days ago) WEBSecondary breast cancer is when a cancer which originated in the breast has spread to other organs or bone. The breast cancer team at Barts Health includes: Consultant breast surgeon. A doctor specifically trained for the surgical treatment of breast cancer. …

https://www.bartshealth.nhs.uk/breast-cancer

Category:  Cancer Show Health

Immunotherapy significantly reduces recurrence in aggressive …

(4 days ago) WEBAn immunotherapy drug called ‘pembrolizumab’ has been shown to significantly reduce disease recurrence in patients with the most aggressive type of …

https://www.bartscancer.london/in-the-media/2022/02/new-drug-combination-significantly-reduces-recurrence-in-aggressive-breast-cancer/

Category:  Health Show Health

New drug combination for aggressive breast cancer could …

(7 days ago) WEBStudy lead, Professor Peter Schmid from Queen Mary University of London's Barts Cancer Institute and Clinical director at St Bartholomew's Hospital said: “We had …

https://www.qmul.ac.uk/media/news/2022/smd/new-drug-combination-for-aggressive-breast-cancer-could-save-thousands-of-lives.html

Category:  Cancer Show Health

NHS England » NHS strikes deal for potentially life-saving …

(9 days ago) WEBSpecialised commissioning. The NHS will roll out an innovative, potentially life-saving treatment for one of the most aggressive forms of breast cancer thanks to a …

https://www.england.nhs.uk/2022/11/nhs-strikes-deal-for-potentially-life-saving-breast-cancer-drug/

Category:  Cancer Show Health

Professor Peter Schmid - Barts Cancer Institute - Queen Mary …

(Just Now) WEBPembrolizumab for Early Triple-Negative Breast Cancer. N Engl J Med (2020) 382(9):810-821. PMID: 32101663 Pembrolizumab plus chemotherapy versus placebo plus …

https://www.bartscancer.london/staff/professor-peter-schmid/

Category:  Cancer Show Health

Association Between Biomarkers and Clinical Outcomes of …

(1 days ago) WEB4 Barts Health NHS Trust, London, United Kingdom. 5 International Breast Cancer Center (IBCC), Pangaea Oncology, Quironsalud Group, Madrid, NCT02447003), first-line …

https://pubmed.ncbi.nlm.nih.gov/37099733/

Category:  Cancer Show Health

First immunotherapy success for triple-negative breast …

(1 days ago) WEBNew research led by St Bartholomew’s Hospital with Queen Mary University of London has shown that by using a combination of immunotherapy and chemotherapy the body’s own …

https://www.bartshealth.nhs.uk/news/first-immunotherapy-success-for-triplenegative-breast-cancer-4557

Category:  Health Show Health

Atezolizumab plus nab-paclitaxel as first-line treatment …

(3 days ago) WEBIn this randomised, placebo-controlled, double-blind, phase 3 trial, done in 246 academic centres and community oncology practices in 41 countries, patients aged 18 years or older, with previously untreated, …

https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30689-8/fulltext

Category:  Health Show Health

Secondary breast cancer treatment Breast Cancer Now

(6 days ago) WEB1. Treatment for secondary (metastatic) breast cancer. If your breast cancer has spread to another part of your body, you may be offered 1 or more different treatments. …

https://breastcancernow.org/about-breast-cancer/secondary-breast-cancer/secondary-breast-cancer-treatment/

Category:  Cancer Show Health

Phase 2 study of pembrolizumab (pembro) monotherapy for …

(8 days ago) WEB1008 Background: In KEYNOTE-012, pembro showed durable activity and manageable safety in patients (pts) with PD-L1+ mTNBC. Cohort A of KEYNOTE-086 …

https://ascopubs.org/doi/10.1200/JCO.2017.35.15_suppl.1008

Category:  Health Show Health

Second Cancers: Developing a New Cancer after Breast Cancer

(4 days ago) WEBBut some cancer survivors develop a new, unrelated cancer later on. This is called a second cancer. Women who’ve had breast cancer can still get other cancers. Although …

https://www.cancer.org/cancer/types/breast-cancer/living-as-a-breast-cancer-survivor/second-cancers-after-breast-cancer.html

Category:  Cancer Show Health

IMpassion132 double-blind randomised phase III trial of - PubMed

(1 days ago) WEBBackground: Immune checkpoint inhibitors improve the efficacy of first-line chemotherapy for patients with programmed death-ligand 1 (PD-L1)-positive unresectable locally …

https://pubmed.ncbi.nlm.nih.gov/38755096/

Category:  Health Show Health

Treatment options for secondary breast cancer

(7 days ago) WEBThere are a number of treatments for secondary breast cancer. You might have a type of treatment on its own or a combination of these treatments: hormone therapy. …

https://www.cancerresearchuk.org/about-cancer/breast-cancer/secondary/treatment-options

Category:  Cancer Show Health

British Society of Breast Radiology Virtual Annual Scientific …

(4 days ago) WEBBarts Health NHS Trust, London, United Kingdom Correspondence: Anam Ali. 33% B2 (reactive nodes, fibroadenoma, fat necrosis) 7% B3 (papillomas), 50% …

https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-021-01471-2

Category:  Health Show Health

Real world study of sacituzumab govitecan in metastatic triple

(Just Now) WEBTreatment options for pre-treated patients with metastatic triple-negative breast cancer (mTNBC) remain limited. This is the first study to assess the real-world …

https://www.nature.com/articles/s41416-024-02685-9

Category:  Cancer Show Health

A real-world study of treatment sequences and second-line

(Just Now) WEBHuman epidermal growth factor receptor 2 (HER2)-overexpressing breast cancer (HER2 + tumors) is an aggressive subtype that has been associated with …

https://link.springer.com/article/10.1007/s10147-024-02492-5

Category:  Cancer Show Health

The clinical and molecular landscape of breast cancer in …

(Just Now) WEBrecords from Discovery East London programme or secondary care records from Barts Health NHS Trust and NHS Digital. We filtered the available data to define …

https://www.medrxiv.org/content/10.1101/2024.05.15.24307435v1.full.pdf

Category:  Health Show Health

Abstract PD1-11: Mature survival update of the double-blind …

(8 days ago) WEBAbstract. Background: In the PAKT study, addition of the oral AKT inhibitor capivasertib to 1st-line paclitaxel therapy for metastatic TNBC resulted in significantly …

https://aacrjournals.org/cancerres/article/81/4_Supplement/PD1-11/647958/Abstract-PD1-11-Mature-survival-update-of-the

Category:  Health Show Health

LBA76 Overall survival (OS) results from the phase III TROPiCS-02 …

(1 days ago) WEBPts with HR+/HER2- mBC are treated with endocrine-based therapy (ET), followed by single-agent chemotherapy (CT), with increasingly shorter durations of benefit. SG is an …

https://www.annalsofoncology.org/article/S0923-7534(22)03890-X/fulltext

Category:  Health Show Health

Treatment of Stage IV (Metastatic) Breast Cancer

(5 days ago) WEBFor women with stage IV breast cancer, systemic drug therapies are the main treatments. These may include: Surgery and/or radiation therapy may be useful in certain situations …

https://www.cancer.org/cancer/types/breast-cancer/treatment/treatment-of-breast-cancer-by-stage/treatment-of-stage-iv-advanced-breast-cancer.html

Category:  Cancer Show Health

Health-related quality of life with sacituzumab govitecan in

(1 days ago) WEBBackground: The TROPiCS-02 study (NCT03901339) demonstrated that sacituzumab govitecan (SG) has superior clinical outcomes over treatment of physician's choice …

https://pubmed.ncbi.nlm.nih.gov/38748596/

Category:  Health Show Health

Phase 2 study of pembrolizumab as first-line therapy for PD …

(8 days ago) WEB1088 Background: Standard first-line treatment for mTNBC is chemotherapy. However, outcomes are poor, and new treatment options are needed. …

https://ascopubs.org/doi/10.1200/JCO.2017.35.15_suppl.1088

Category:  Health Show Health

Breast cancer survivors’ risk of secondary cancers studied by

(7 days ago) WEBWith improvements in earlier diagnosis and treatments, five-year survival rates reached 87 per cent by 2017 in England. Those who survive breast cancer are known to be at risk …

https://www.msn.com/en-us/health/other/breast-cancer-survivors-risk-of-secondary-cancers-studied-by-university-of-cambridge-researchers/ar-BB1m9yMT

Category:  Cancer Show Health

Higher Risk Breast Cancer Screening: Which Test to Use? - Medscape

(Just Now) WEBThat incremental cancer detection rate beat out rates for handheld ultrasound (0.35 per 1000 screenings), automated breast ultrasound (0.26 per 1000 screenings), …

https://www.medscape.com/viewarticle/higher-risk-breast-cancer-screening-which-test-use-2024a100099v

Category:  Cancer Show Health

The clinical and molecular landscape of breast cancer in women of

(1 days ago) WEBBreast cancer is the most commonly diagnosed cancer globally and the leading cause of cancer death in women, with ethnic disparities reported in cancer …

https://www.medrxiv.org/content/10.1101/2024.05.15.24307435v1

Category:  Cancer Show Health

Breast Cancer Basics Breast Cancer CDC - Centers for Disease

(Just Now) WEBThere are several other less common kinds of breast cancer, such as Paget's disease, medullary, mucinous, and inflammatory breast cancer. Ductal …

https://www.cdc.gov/breast-cancer/about/index.html

Category:  Cancer Show Health

Cancer Care & Prevention - Cleveland Clinic

(5 days ago) WEB6 Ways To Boost Breast Health Taking precautions like eating healthy, stopping smoking and getting regular screenings can help protect against breast cancer …

https://health.clevelandclinic.org/health-conditions/cancer-care-prevention

Category:  Cancer Show Health

Corrigendum to “The Effect of Melatonin on Increasing the Health

(3 days ago) WEBThe Effect of Melatonin on Increasing the Health Related Quality of Life in Non-Metastatic Breast Cancer Patients: Three-Year Follow up a Clinical Trial.

https://journals.sagepub.com/doi/full/10.1177/15347354241257965

Category:  Cancer Show Health

Filter Type: